![Galangin may sensitize apoptosis-resistant renal carcinoma cells [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2016/01/Papillary_renal_cell_carcinoma_-_very_high_mag-350x250.jpg)
Nivolumab and cabozantinib superior to sunitinib for advanced renal-cell carcinoma
1. The combination of nivolumab and cabozantinib was superior to sunitinib in untreated advanced renal-cell carcinoma 2. The combination treatment ...
Tag: renal-cell carcinoma
Cabozantinib improves progression-free survival in patients with metastatic papillary renal cell carcinoma
1. Progression-free survival was longer in patients in the cabozantinib group (9.0 months) than in the sunitinib group (5.6 months). ...
Sunitinib increases disease free survival in high risk renal carcinoma post nephrectomy
1. In patients with locoregional clear-cell renal cell carcinoma (RCC) at high risk of recurrence post nephrectomy, those taking sunitinib ...
Galangin may sensitize apoptosis-resistant renal carcinoma cells [PreClinical]
1. Galangin caused increased cell death in a renal cancer cell line that is resistant to tumor necrosis factor-related apoptosis-inducing ...
Radiographic surrogates may predict tumor-specific survival in renal carcinoma
1. Computed tomography derived imaging characteristics were correlated with disease specific gene expression to create a radiogenomic based surrogate of ...
Mixed picture for pazopanib versus sunitinib in metastatic renal-cell carcinoma
Image: PD 1. Pazopanib and sunitinib showed similar efficacy in treating metastatic renal-cell carcinoma as a first-line therapy. 2. Quality-of-life ...
